article thumbnail

NHC Submits Comments on CMS Draft Guidance for IPAY 2028

Putting Patients First Blog

24 To ensure that listening sessions yield actionable, patient-centered insights, the NHC recommends the following process improvements focused on accessibility, clarity, and broad participation of stakeholders: CMS should provide a minimum of 30 days’ advance notice and allow scheduling flexibility for all listening sessions.

article thumbnail

IPA questions FAERS data interpretation in the Ohio State University study

Express Pharma

It attributed Indias cost advantage to high-production capacity plants, process improvements, economies of scale, and backward integration in manufacturing. It has also introduced the Foreign Unannounced Inspection Pilot programme, conducting multiple unannounced and short-term notice inspections in India since March 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

207 community hospital presidents and CEOs to know | 2025

Beckers Hospital Review

Mr. Calhoun has propelled Citizens Memorial Hospital into rural healthcare excellence since becoming CEO in 2022. Since November 2022, Mr. Farell has been responsible for overseeing the daily operations of St. Fast was appointed in July 2022 and leads St. Michael Calhoun. CEO of Citizens Memorial Hospital (Bolivar, Mo.).

article thumbnail

Single-use technology propelling upstream bioprocessing market expansion

European Pharmaceutical Review

percent between 2022 and 2029. The rising productivity of cell lines has improved the performance of upstream processing with low cost and high process reproducibility, the report explained. A report from Data Bridge Market Research has predicted that the upstream bioprocessing market will value $14,256.78

article thumbnail

Automation to guide technology shift in aseptic environments

European Pharmaceutical Review

Recently, the European Medicines Agency (EMA) took the lead in pushing for process improvements using technologies already established in other manufacturing sectors. Significance of Annex 1–2022 for implementing Pharma 4.0 One of these key technologies is automation, a recent paper explained. Tanzini et al.

article thumbnail

The next frontier: Global leadership in biopharma

Express Pharma

Biswas outlines, “Adopting advanced manufacturing technologies, including continuous processing, digitally programmed manufacturing systems (MES) and deep learning based continuous process improvements are factors that hold immense promise for transforming biopharma production. times in seven years.”

article thumbnail

Laboratory services poised for the digital revolution

Pharmaceutical Technology

For Jamaels, whose track record in managing complex operations and delivering process improvements spans GSK Vaccines and one of the world’s largest companies, GE, the technological shift is an exciting development: “I’m passionate about the digital transformation that our industry is going through,” he says.